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In this issue of Cell Host & Microbe, Bloom and colleagues elegantly show that commensal Bacteroides
species fulfill Koch’s postulates for inflammatory bowel disease in a host-genotype-specific way. This study
showcases the use of a non-germ-free mouse model to identify specific members of the microbiota involved
in disease development.Inflammatory bowel disease (IBD) refers to
a group of chronic and relapsing inflamma-
tory conditions of the gastrointestinal tract,
most notably ulcerative colitis and Crohn’s
disease. The etiology of IBD is poorly
defined; however, genetics, environment,
and gut microbes all play a role in these
multifactorial diseases (Matricon et al.,
2010). Genome-wide association studies
have revealed that host genetics play an
important role in susceptibility with approx-
imately 100 susceptibility loci having been
identified (Sun et al., 2011). Many of these
genes play a role in pathways involved in
sensing and responding to the microbiota.
The role of the microbiota in the pathogen-
esis of IBD is inferred through both clinical
and laboratory data, including the facts
that remission ensues following diversion
of fecal flow, that antibiotic treatment often
ameliorates thedisease,and thatgerm-free
mice do not develop spontaneous colitis
(Sartor, 2008). The initial search for patho-
genic organisms that might cause disease
suggested E. coli and Mycobacterium
aviumparatuberculosisas potential culprits
(Sartor, 2008).However, the inability to fulfill
Koch’s postulates and consistently find
a single pathogen resulted in a theory that
disease was associated with an imbal-ancedmicrobial population or ‘‘dysbiosis.’’
Consistent with this theory, the microbiota
in IBD patients exhibits an abnormal
composition with decreased abundance
of Firmicutes and Bacteroidetes and
concomitant increase of Proteobacteria,
particularly Enterobacteriaceae, and Acti-
nobacteria compared to healthy individuals
(Sokol et al., 2008). However, the question
remains whether changes in microbial
composition are playing a causal role in
disease induction, or if they are simply a
product of inflammation and only symp-
tomatic of the condition.
Currently, little is known about the roles
of specific bacteria in the pathology of IBD
in a host-specific context, anddiseasehas
not been consistently associated with a
specific bacterium (Frank et al., 2007;
Sartor, 2008). Studies on the impact of
specific intestinal bacteria in IBD develop-
ment have been performed (Garrett et al.,
2010; Rhee et al., 2009). However, they
rely mainly on germ-free mice, which rai-
ses questions regarding the validity of the
results, due to the altered immune status
of these mice, as well as their relevance
in studying the disease in IBD patients.
Bloom and colleagues (Bloom et al.,
2011) shed light on the issue by using aconventionally raised mouse model that
is genetically susceptible to IBD. With a
normal microbiota, these genetically
susceptible mice spontaneously develop
colitis. However, by depleting some
members of the normal microbiota with
antibiotics, they were able to prevent co-
litis. They were then able to restore colitis
by introducing commensal Bacteroides
species isolated from healthy mice, but
not with members of the Firmicutes or
Proteobacteria phyla. When these same
Bacteroides species were introduced
into antibiotic-pretreated nonsusceptible
mice, they colonized to the same levels
as susceptible mice but did not cause
any signs of disease, indicating the geno-
type-specific nature of this harmful inter-
action. In susceptible mice, Bacteroides
activated both innate and adaptive im-
mune responses, consistent with clinical
observations in IBD patients. Of particular
importance to the theory of dysbiosis in
IBD, Bacteroides species were not partic-
ularly enhanced in diseased mice, sug-
gesting that they would not have been
predicted to have a disease-inducing
potential. Conversely, members of the
Enterobacteriaceae family were increased
in IBD-susceptible mice, similar to othere 9, May 19, 2011 ª2011 Elsevier Inc. 353
Cell Host & Microbe
Previewsreports (Willing et al., 2010). However,
when an E. coli isolated from these mice
was introduced to genetically susceptible
mice, colitis was not restored.
In healthy individuals, the intestinal
microbiota has a symbiotic relationship
with its host, being beneficial in numerous
biological processes required for optimal
health. In IBD patients, the relationship
between the individual’s immune toler-
ance and the intestinal bacteria is disrup-
ted, leading to increased immune stimula-
tion, epithelial dysfunction, and enhanced
mucosal permeability (Frank and Pace,
2008). Commensal Bacteroides are pre-
sent in abundance in the mammalian
microbiota, and they have a beneficial
impact on the host through the break-
down of complex dietary carbohydrates,
modulation of mucosal glucosylation,
immune maturation, etc. However, as
illustrated in this article, even beneficial
members of the microbiota can have
detrimental effects, depending on the
host genetic background.
There are certainly more questions that
need to be addressed, but this paper
presents an important first step. Ques-
tions that remain include: what other
bacteria might be involved in the disease;354 Cell Host & Microbe 9, May 19, 2011 ª20what mechanisms are involved in their
ability to induce disease; are these popu-
lations important only for these genetic
loci, or are different bacteria responsible
for disease when other genetic factors
are involved? Overall, this work highlights
the fact that both host genetics and
bacterial colonization are important in
the development of the disease. There-
fore, studies to further determine how
IBD develops should consider both these
factors. Our knowledge of the causes of
IBD is in its infancy, but this work
develops a feasible non-germ-free model
to screen for colitogenic bacteria in a
host-genotype-specific fashion. There-
fore, this experimental model could be
used to test different subsets of bacteria,
as well as additional genetically suscep-
tible hosts. Understanding the mecha-
nisms and players of IBD pathogenesis
will likely draw more attention to the
modulation of the intestinal community
as a novel source of IBD treatment.
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